Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice

被引:27
作者
Kang, Myung-Soo [2 ]
Soni, Vishal [2 ]
Bronson, Roderick
Kieff, Elliott [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Div Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.1128/JVI.02596-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To test whether transgenic Epstein-Barr virus nuclear antigen 1 (EBNA1) expression in C57BL/6 mouse lymphocytes causes lymphoma, EBNA1 expressed in three FVB lineages at two or three times the level of latent infection was crossed up to six successive times into C57BL/6J mice. After five or six crosses, 14/36, (38%) EBNA1 transgenic mice, 11/31 (36%) littermate EBNA1-negative controls, and 9/25 (36%) inbred C57BL/6J mice housed in the same facility had lymphoma. These data indicate that EBNA1 does not significantly increase lymphoma prevalence in C57BL/6J mice.
引用
收藏
页码:4180 / 4183
页数:4
相关论文
共 49 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]  
ADAMS JM, 1986, CURR TOP MICROBIOL, V132, P1
[3]   Hematopoietic neoplasia in C57BL/6 mice exposed to split-dose ionizing radiation and circularly polarized 60 Hz magnetic fields [J].
Babbitt, JT ;
Kharazi, AI ;
Taylor, JMG ;
Bonds, CB ;
Mirell, SG ;
Frumkin, E ;
Zhuang, DL ;
Hahn, TJ .
CARCINOGENESIS, 2000, 21 (07) :1379-1389
[4]   Increased body weight in C57BL/6 female mice after exposure to ionizing radiation or 60 Hz magnetic fields [J].
Babbitt, JT ;
Kharazi, AI ;
Taylor, JMG ;
Bonds, CB ;
Zhuang, D ;
Mirell, SG ;
Frumkin, E ;
Hahn, TJ .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2001, 77 (08) :875-882
[5]   EPSTEIN-BARR-VIRUS LATENT GENE-TRANSCRIPTION IN NASOPHARYNGEAL CARCINOMA-CELLS - COEXPRESSION OF EBNA1, LMP1, AND LMP2 TRANSCRIPTS [J].
BROOKS, L ;
YAO, QY ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF VIROLOGY, 1992, 66 (05) :2689-2697
[6]   Successes and risks of gene therapy in primary immunodeficiencies [J].
Chinen, J ;
Puck, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (04) :595-603
[7]   EPSTEIN-BARR VIRUS NUCLEAR PROTEIN-2 IS A KEY DETERMINANT OF LYMPHOCYTE-TRANSFORMATION [J].
COHEN, JI ;
WANG, F ;
MANNICK, J ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9558-9562
[8]   EBNA3A association with RBP-Jκ down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth [J].
Cooper, A ;
Johannsen, E ;
Maruo, S ;
Cahir-McFarland, E ;
Illanes, D ;
Davidson, D ;
Kieff, E .
JOURNAL OF VIROLOGY, 2003, 77 (02) :999-1010
[9]  
Cory S, 1987, Haematol Blood Transfus, V31, P248
[10]   EPSTEIN-BARR-VIRUS AND HODGKINS-DISEASE - TRANSCRIPTIONAL ANALYSIS OF VIRUS LATENCY IN THE MALIGNANT-CELLS [J].
DEACON, EM ;
PALLESEN, G ;
NIEDOBITEK, G ;
CROCKER, J ;
BROOKS, L ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :339-349